Repression of retinoic acid receptor signaling by Ski in prognostically unfavorable forms of acute myeloid leukemia
نویسندگان
چکیده
1. Klinik für Innere Medizin mit SP Hämatologie, Onkologie und Immunologie, PhilippsUniversität Marburg, Baldinger Strasse, 35043 Marburg, Germany 2. Institut für Medizinische Biometrie und Epidemiologie; Philipps-Universität, Bunsenstraße 3, 35037 Marburg, Germany 3. Institut für Molekularbiologie und Tumorforschung, Philipps-Universität, Emil-MannkopffStr. 2, 35037 Marburg, Germany 4. Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus, Fetscherstr. 74, 01307 Dresden, Germany 5. Department of Molecular Genetics and Microbiology, Stony Brook University, Stony Brook, New York 11794-5222, USA
منابع مشابه
Cytogenetic and FMS-Like Tyrosine Kinase 3 Mutation Analyses in Acute Promyelocytic Leukemia Patients
Background: The secondary genetic changes other than the promyelocytic leukemia-retinoic acid receptor (PML-RARA) fusion gene may contribute to the acute promyelocytic leukemogenesis. Chromosomal alterations and mutation of FLT3 (FMS-like tyrosine kinase 3) tyrosine kinase receptor are the frequent genetic alterations in acute myeloid leukemia. However, the prognostic significance of FLT3 mutat...
متن کاملHistone deacetylase-targeted treatment restores retinoic acid signaling and differentiation in acute myeloid leukemia.
Histone deacetylase (HDAC)-dependent transcriptional repression of the retinoic acid (RA)-signaling pathway underlies the differentiation block of acute promyelocytic leukemia. RA treatment relieves transcriptional repression and triggers differentiation of acute promyelocytic leukemia blasts, leading to disease remission. We report that transcriptional repression of RA signaling is a common me...
متن کاملHeterochromatic gene repression of the retinoic acid pathway in acute myeloid leukemia.
Alteration of lineage-specific transcriptional programs for hematopoiesis causes differentiation block and promotes leukemia development. Here, we show that AML1/ETO, the most common translocation fusion product in acute myeloid leukemia (AML), counteracts the activity of retinoic acid (RA), a transcriptional regulator of myelopoiesis. AML1/ETO participates in a protein complex with the RA rece...
متن کاملClearance of PML/RARA-bound promoters suffice to initiate APL differentiation.
PML/RARA, a potent transcriptional inhibitor of nuclear receptor signaling, represses myeloid differentiation genes and drives acute promyelocytic leukemia (APL). Association of the retinoid X receptor-α (RXRA) coreceptor to PML/RARA is required for transformation, with RXRA promoting its efficient DNA binding. APL is exquisitely sensitive to retinoic acid (RA) and arsenic trioxide (arsenic), w...
متن کاملActive repression by unliganded retinoid receptors in development
The retinoid receptors have major roles throughout development, even in the absence of ligand. Here, we summarize an emerging theme whereby gene repression, mediated by unliganded retinoid receptors, can dictate cell fate. In addition to activating transcription, retinoid receptors actively repress gene transcription by recruiting cofactors that promote chromatin compaction. Two developmental p...
متن کامل